Consistent with the reduction in liver lipid accumulation, we found that the gene expression of these key lipid metabolism genes (ACC, FAS, SCD1, CHREBP1, SREBP1) was significantly upregulated in the STE group, the increase of CPT1 expression can accelerate the transport of fatty acids to mitochondria, enhance β-oxidation, and reduce the accumulation of triglycerides in hepatocytes, thus alleviating steatosis. The gene discussed is SREBF1; the disease is steatosis.